Elanco Animal Health Q3 Adj. EPS $0.18 Beats $0.12 Estimate, Sales $1.07B Beat $1.04B Estimate
Portfolio Pulse from Benzinga Newsdesk
Elanco Animal Health (NYSE:ELAN) reported Q3 earnings of $0.18 per share, beating the analyst consensus estimate of $0.12 by 50%. However, this is a 10% decrease from the same period last year. The company also reported quarterly sales of $1.07 billion, beating the estimate of $1.04 billion by 2.69%, and marking a 3.89% increase from the same period last year.
November 07, 2023 | 11:36 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Elanco's Q3 earnings and sales beat estimates, but earnings per share decreased by 10% YoY. Sales increased by 3.89% YoY.
Elanco's earnings beat estimates, which is generally positive for the stock. However, the 10% YoY decrease in earnings per share might concern some investors. The increase in sales is a positive sign and could offset some of the concerns about the decrease in earnings.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100